The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: ranibizumab     Quarter: 2016Q3

Total Drug/Injury Combinations: 133     Number of Pages: 7

DRUGNAME PT EventCount
Ranibizumab Visual acuity reduced 29 view events
Ranibizumab Detachment of retinal pigment epithelium 23 view events
Ranibizumab Cataract 22 view events
Ranibizumab Inappropriate schedule of drug administration 20 view events
Ranibizumab Ocular hypertension 17 view events
Ranibizumab Headache 16 view events
Ranibizumab Retinal haemorrhage 15 view events
Ranibizumab Cerebrovascular accident 14 view events
Ranibizumab Eye pain 13 view events
Ranibizumab Keratitis 13 view events
Ranibizumab Cystoid macular oedema 12 view events
Ranibizumab Intraocular pressure increased 12 view events
Ranibizumab Coronary artery occlusion 11 view events
Ranibizumab Nephrolithiasis 11 view events
Ranibizumab Subretinal fluid 11 view events
Ranibizumab Vitreous haemorrhage 11 view events
Ranibizumab Cerebral infarction 10 view events
Ranibizumab Fall 10 view events
Ranibizumab Macular degeneration 10 view events
Ranibizumab Pain in extremity 10 view events

Total Drug/Injury Combinations: 133     Number of Pages: 7

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)